Worldwide GLP-1 Receptor Agonist Market Research Report 2021 by Type, Application, Participants and Countries, Forecast Year to 2026
- PRO4355103
- 132 Pages
- March 2021
- Healthcare
The worldwide glp-1 receptor agonist market is readied to witness consistent growth through 2030
New item launches stay an essential emphasis location for market players
The United States and Canada as well as Europe collectively hold greater than 70% of market share, with the us holding the lions share
Covid-19 to delay the market in the short-term, with recovery expected in the very first quarter of 2021
Glp-1 receptor agonist market photo
Globally, nearly 463 mn people in between 20 and also 70 years old are approximated to be struggling with diabetic issues, as per the international diabetes federation in 2019.
Additionally, based on who, over 1.9 mn grownups were discovered to be overweight as of 2016. overweight as well as obese individuals go to a better threat of establishing cardio and also gastric conditions as well as diabetes mellitus.
The glp-1 receptor agonist market is affected by an increase in the variety of individuals categorized as obese or identified as diabetics. a growth in these numbers is most likely to press fostering of glp-1 receptor agonists over the projection period.
Brand-new product launches stay crucial to growth
Glp-1 receptor agonist market players are tabling new products to get an affordable advantage over each other. this pattern is bound to drive the market in the projection duration.
In june 2020, sunlight pharmaceuticals revealed an updation concerning its pre-clinical module. the experimental nce (brand-new chemical entity) finds as a long-acting glp-1r agonist for dealing with individuals struggling with kind 2 diabetes mellitus inclusive of long-acting, intermediate-acting, as well as short-acting therapies
In jun 2020, pfizer showcased phase i information from study evaluating pf-06882961, a glp-1r agonist in the people contracting kind 2 diabetic issues at the online American diabetes organization meeting. the searchings for showed that this glp-1 receptor agonist considerably reduced body weight and also glucose degrees in these patients
In jun 2020, novo nordisk tabled arise from a real-world research, path that expands support to referrals in professional standards by showcasing that launching a glp-1 receptor agonist does assist people influenced by kind 2 diabetic issues in weight-loss along with reaching blood sugar level degrees.
In jun 2020, novo nordisk announced the authorization of rybelsus (dental semaglutide) (the sole dental glp-1 r agonist in the type of a tablet computer) from the Japanese ministry of our analystsllness, work and welfare to treat people with kind 2 diabetic issues
In apr 2020, astrazeneca moneyed a medical trial to examine usage of short-acting glp-1 receptor agonists as one of the add-on treatments to insulin treatment in the type 1 diabetes mellitus.
Glp-1 receptor agonist market: r& d activities as per scientists at the icahn college of medicine, beta cells can be regrowed at a lot greater prices by combining dyrk1a medications with glp-1 receptor agonists.
The glp-1 receptor agonists might be any of the recommended meds like bydureon from astrazeneca, trulicity from eli lilly, rybelsus, ozempic, and victoria from novo nordisk.
Diabetes mellitus care, released research study results mentioning that treatment with lixisenatide glp-1 receptor agonist dramatically reduces stomach emptying and also lowers postprandial glycaemia. in may 2017, diabetes mellitus, excessive weight and also metabolism published that the ones experiencing kind 2 diabetes mellitus witnessed lower regularity of gastrointestinal occasions with a weekly dosage of exenatide (a glp-1 receptor agonist).
The lancet diabetic issues & endocrinology, in jan 2020, published that glp-1 receptor agonists could be taken into consideration while going for future stroke prevention standards for those struggling with diabetes mellitus.
Likewise, in sep 2019, researchers at the 55th yearly meeting of the European organization for the research of diabetes mellitus, reported that a new glp-1 receptor agonist called pex168 showed favorable outcomes relative to therapy of those experiencing type 2 diabetes mellitus
Covid-19 effect on glp-1 receptor agonist market
The outbreak of covid-19 has actually decreased the regularity of research study as well as approvals for glp-1 receptor agonists this circumstance is anticipated to continue till completion of the year 2020. the normality is expected to obtain brought back by the initial quarter of the year 2021.
Glp-1 receptor agonist market: region-wise evaluation
North America held even more than 70% of market share in the year 2019. this can be connected to the ever-increasing application of glp-1 receptor agonists in addition to a reputable demand-supply chain being composed of pharmaceutical and also biopharmaceutical market.
Europe is the second largest market for glp-1 receptor agonist, and the growing weight problems rates in the area are most likely to boost fostering over the forecast period. according to the who likewise specifies that around 60 million individuals all across the Europe are dealing with diabetic issues.
Asia pacific is anticipated to expand at the fastest rate in the projection duration as a result of the reality that greater than 70% of the international diabetic population resides in India as well as China. additionally, 40.9% of the population is found to be overweight (as per adb institute).
Glp-1 receptor agonist market: competition landscape
The glp-1 receptor agonist market players are adopting diverse strategies like geographical growth and also mergings as well as purchases (m& a)for obtaining a strong foothold.
For circumstances, sanofi, in jan 2020, made a statement of acquiring synthorx, inc. this purchase is most likely to assist the company to lay its hands on genetic alphabet platform technology.
Research study cooperations between the players for establishing brand-new items have also been relocating in the direction of market confirmation.
For example, boehringer ingelheim as well as eli lilly as well as firm, in dec 2018, worked together with dcri (battle each other professional study institute) to establish glp-1 receptor agonist for addressing cardio conditions and diabetes mellitus.
Along with eli lily and company, as well as sanofi, vital gamers in the glp-1 receptor agonist market include novo nordisk as well as astrazeneca.
Glp-1 receptor agonist market: the means forward
The glp-1 receptor agonist market is expected to be going solid, with We evaluation anticipating consistent growth between 2020 and also 2030. research study as well as cutting-edge methods are expected to drive the marketplace in the close to future.
The crucial market gamers need to consider getting to out to wider locations with inorganic expansion, so regarding deal with a bigger patient-base. developments are currently on the anvil. they, combined with mergers, acquisitions, collaborations, joint ventures will contribute to the affordable landscape
Key segment
Medication course
Exenatide
Liraglutide
Dulaglutide
Lixisenatide
Others
Course of administration
Parenteral
Oral
Distribution network
Healthcare facilities
Centers
Ambulatory medical centres
Region
North America
Latin America
Europe
Eastern Asia
South Asia
Oceania
Center eastern and Africa
1. Introduction
1.1 Definition of the Market
1.2 Research Purpose
1.3 Scope of the Study
1.4 Stakeholders
1.5 Geography Coverage
1.6 Currency Under Consideration
1.7 Volume Units
1.8 Review Cycle
1.9 Summary and Key Findings of the Research
2 Research Methodology
2.1 Research Data
2.1.1 Secondary Data
2.1.2 Primary Data
2.2 Market Size Estimation
2.2.1 Bottom-Up Approach
2.2.2 Top-Down Approach (Involves time, Space, and Persons)
2.3 Data Triangulation
2.4 Assumptions
2.5 Hypothesis of this Research, Clear, specific, and testable statement of this research
2.6 Limitations of Our Study
2.7 Scene Based Modeling
2.8 Covid-19 Impact/Evaluation
3. Market Dynamics
3.1 Driving Factors
3.1.1 Rising Demand in one or More of the Following Regions: North America, Europe, Asia-Pacific, Latin America, Middle East & Africa
3.1.2 Increasing Use of GLP-1 Receptor Agonist by Different End-User/Applications
3.2 Restraints and Challenges in the Market
3.3 Opportunities
4. Global GLP-1 Receptor Agonist Market-Segmentation
4.1 By Type
…
4.2 By End-User/Application Industry
…
4.3 By Geography
4.3.1 North America GLP-1 Receptor Agonist Total Market Size (Production, Consumption, Import, Export) and Segmentation (by Type, Application, Countries and Participants)
4.3.1.1 North America GLP-1 Receptor Agonist Production from 2014-2020
4.3.1.2 North America GLP-1 Receptor Agonist Consumption from 2014-2020
4.3.1.3 North America GLP-1 Receptor Agonist Import and Export from 2014-2020
4.3.1.4 North America GLP-1 Receptor Agonist Market Value ($) and Growth (%) by Type from 2019-2020
4.3.1.5 North America GLP-1 Receptor Agonist Market Value ($) and Growth (%) by Application from 2019-2020
4.3.1.6 North America GLP-1 Receptor Agonist Market Value ($) and Growth (%) by Countries from 2019-2020
4.3.1.7 Top North America GLP-1 Receptor Agonist Participants Value ($) and Market Share (%) in 2020
4.3.2 Europe GLP-1 Receptor Agonist Total Market Size (Production, Consumption, Import, Export) and Segmentation (by Type, Application, Countries and Participants)
4.3.2.1 Europe GLP-1 Receptor Agonist Production from 2014-2020
4.3.2.2 Europe GLP-1 Receptor Agonist Consumption from 2014-2020
4.3.2.3 Europe GLP-1 Receptor Agonist Import and Export from 2014-2020
4.3.2.4 Europe GLP-1 Receptor Agonist Market Value ($) and Growth (%) by Type from 2019-2020
4.3.2.5 Europe GLP-1 Receptor Agonist Value ($) and Growth (%) by Application from 2019-2020
4.3.2.6 Europe GLP-1 Receptor Agonist Market Value ($) and Growth (%) by Countries from 2019-2020
4.3.2.7 Top Europe GLP-1 Receptor Agonist Participants Value ($) and Market Share (%) in 2020
4.3.3 Asia-Pacific GLP-1 Receptor Agonist Total Market Size (Production, Consumption, Import, Export) and Segmentation (by Type, Application, Countries and Participants)
4.3.3.1 Asia-Pacific GLP-1 Receptor Agonist Production from 2014-2020
4.3.3.2 Asia-Pacific GLP-1 Receptor Agonist Consumption from 2014-2020
4.3.3.3 Asia-Pacific GLP-1 Receptor Agonist Import and Export from 2014-2020
4.3.3.4 Asia-Pacific GLP-1 Receptor Agonist Value ($) and Growth (%) by Type from 2019-2020
4.3.3.5 Asia-Pacific GLP-1 Receptor Agonist Value ($) and Growth (%) by Application from 2019-2020
4.3.3.6 Asia-Pacific GLP-1 Receptor Agonist Value ($) and Growth (%) by Countries from 2019-2020
4.3.3.7 Top Asia-Pacific GLP-1 Receptor Agonist Participants Value ($) and Market Share (%) in 2020
4.3.4 Latin America GLP-1 Receptor Agonist Total Market Size (Production, Consumption, Import, Export) and Segmentation (by Type, Application, Countries and Participants)
4.3.4.1 Latin America GLP-1 Receptor Agonist Production from 2014-2020
4.3.4.2 Latin America GLP-1 Receptor Agonist Consumption from 2014-2020
4.3.4.3 Latin America GLP-1 Receptor Agonist Import and Export from 2014-2020
4.3.4.4 Latin America GLP-1 Receptor Agonist Value ($) and Growth (%) by Type from 2019-2020
4.3.4.5 Latin America GLP-1 Receptor Agonist Value ($) and Growth (%) by Application from 2019-2020
4.3.4.6 Latin America GLP-1 Receptor Agonist Value ($) and Growth (%) by Countries from 2019-2020
4.3.4.7 Top Latin America GLP-1 Receptor Agonist Participants Value ($) and Market Share (%) in 2020
4.3.5 Middle East & Africa GLP-1 Receptor Agonist Total Market Size (Production, Consumption, Import, Export) and Segmentation (by Type, Application, Countries and Participants)
4.3.5.1 Middle East & Africa GLP-1 Receptor Agonist Production from 2014-2020
4.3.5.2 Middle East & Africa GLP-1 Receptor Agonist Consumption from 2014-2020
4.3.5.3 Middle East & Africa GLP-1 Receptor Agonist Import and Export from 2014-2020
4.3.5.4 Middle East & Africa GLP-1 Receptor Agonist Value ($) and Growth (%) by Type from 2019-2020
4.3.5.5 Middle East & Africa GLP-1 Receptor Agonist Value ($) and Growth (%) by Application from 2019-2020
4.3.5.6 Middle East & Africa GLP-1 Receptor Agonist Value ($) and Growth (%) by Countries from 2019-2020
4.3.5.7 Top Middle East & Africa GLP-1 Receptor Agonist Participants Value ($) and Market Share (%) in 2020
5. Global Level Competitive Intelligence – Company Profiles
5.1 Company one
5.1.1 Company one Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.1.2 Company one Sales, Growth Rate and Global Market Share from 2014-2020
5.2 Company two
5.2.1 Company two Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.2.2 Company two Sales, Growth Rate and Global Market Share from 2014-2020
5.3 Company three
5.3.1 Company three Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.3.2 Company three Sales, Growth Rate and Global Market Share from 2014-2020
5.4 Company four
5.4.1 Company four Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.4.2 Company four Sales, Growth Rate and Global Market Share from 2014-2020
5.5 Company five
5.5.1 Company five Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.5.2 Company five Sales, Growth Rate and Global Market Share from 2014-2020
5.6 Company six
5.6.1 Company six Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.6.2 Company six Sales, Growth Rate and Global Market Share from 2014-2020
5.7 Company seven
5.7.1 Company seven Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.7.2 Company seven Sales, Growth Rate and Global Market Share from 2014-2020
5.8 Company eight
5.8.1 Company eight Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.8.2 Company eight Sales, Growth Rate and Global Market Share from 2014-2020
5.9 Company nine
5.9.1 Company nine Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.9.2 Company nine Sales, Growth Rate and Global Market Share from 2014-2020
5.10 Company ten
5.10.1 Company ten Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.10.2 Company ten Sales, Growth Rate and Global Market Share from 2014-2020
5.11 Company 11
5.11.1 Company 11 Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.11.2 Company 11 Sales, Growth Rate and Global Market Share from 2014-2020
5.12 Company 12
5.12.1 Company 12 Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.12.2 Company 12 Sales, Growth Rate and Global Market Share from 2014-2020
5.13 Company 13
5.13.1 Company 13 Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.13.2 Company 13 Sales, Growth Rate and Global Market Share from 2014-2020
5.14 Company 14
5.14.1 Company 14 Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.14.2 Company 14 Sales, Growth Rate and Global Market Share from 2014-2020
5.15 Company 15
5.15.1 Company 15 Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.15.2 Company 15 Sales, Growth Rate and Global Market Share from 2014-2020
...
6. Investment Analysis
6.1 Fundamental Analysis (Porter's Five Forces Analysis)
6.2 Technical Preparation Analysis
6.3 Risk Evaluating Analysis
6.4 Estimated Investment Pay-Back Period
7. Future Forecast of Global GLP-1 Receptor Agonist Market from 2020-2026
7.1 Future Forecast of Global GLP-1 Receptor Agonist Market from 2020-2026 Segment by Regions
7.2 Future Forecast of Global GLP-1 Receptor Agonist Market from 2020-2026 Segment by Type
7.3 Future Forecast of Global GLP-1 Receptor Agonist Market from 2020-2026 Segment by Application
8 Appendix
8.1 Discussion Guide
8.2 Related Reports
8.3 Author List
618 Disclaimer
Table Key Data from Secondary Sources
Table Key Data Parameter
Figure Market Size Estimation by End-Use Industry
Figure Market: Data Triangulation
Figure Market Size Estimation: Top-Down Approach
Table Driving Factors for this Market (North America, Europe, Asia-Pacific, Latin America, Middle East & Africa)
Table Global GLP-1 Receptor Agonist Production and Growth Rate Segment by Product Types from 2014-2020
Table Global GLP-1 Receptor Agonist Value ($) and Growth Rate Segment by Product Types from 2014-2020
Figure Type 1 of GLP-1 Receptor Agonist
Figure Type 2 of GLP-1 Receptor Agonist
Figure Type 3 of GLP-1 Receptor Agonist
Table Global GLP-1 Receptor Agonist Consumption and Growth Rate Segment by End-User/Application from 2014-2020
Table Global GLP-1 Receptor Agonist Value ($) and Growth Rate Segment by End-User/Application from 2014-2020
Figure Application 1 of GLP-1 Receptor Agonist
Figure Application 2 of GLP-1 Receptor Agonist
Figure Application 3 of GLP-1 Receptor Agonist
Table Global GLP-1 Receptor Agonist Production Value ($) by Regions
Table Global GLP-1 Receptor Agonist Production Value Share by Regions
Table Global GLP-1 Receptor Agonist Production by Regions
Table Global GLP-1 Receptor Agonist Production Share by Regions
Table Global GLP-1 Receptor Agonist Consumption by Regions
Table Global GLP-1 Receptor Agonist Consumption Share by Regions
Figure North America GLP-1 Receptor Agonist Production and Growth Rate from 2014-2020
Figure North America GLP-1 Receptor Agonist Consumption and Growth Rate from 2014-2020
Table North America GLP-1 Receptor Agonist Import and Export from 2014-2020
Table North America GLP-1 Receptor Agonist Value ($) and Growth (%) by Type from 2019-2020
Table North America GLP-1 Receptor Agonist Value ($) and Growth (%) by Application from 2019-2020
Table North America GLP-1 Receptor Agonist Value ($) and Growth (%) by Countries from 2019-2020
Table Top North America GLP-1 Receptor Agonist Participants Value ($) and Market Share (%) in 2020
Figure Europe GLP-1 Receptor Agonist Production and Growth Rate from 2014-2020
Figure Europe GLP-1 Receptor Agonist Consumption and Growth Rate from 2014-2020
Table Europe GLP-1 Receptor Agonist Import and Export from 2014-2020
Table Europe GLP-1 Receptor Agonist Value ($) and Growth (%) by Type from 2019-2020
Table Europe GLP-1 Receptor Agonist Value ($) and Growth (%) by Application from 2019-2020
Table Europe GLP-1 Receptor Agonist Market Value ($) and Growth (%) by Countries from 2019-2020
Table Top Europe GLP-1 Receptor Agonist Participants Value ($) and Market Share (%) in 2020
Figure Asia-Pacific GLP-1 Receptor Agonist Production and Growth Rate from 2014-2020
Figure Asia-Pacific GLP-1 Receptor Agonist Consumption and Growth Rate from 2014-2020
Table Asia-Pacific GLP-1 Receptor Agonist Import and Export from 2014-2020
Table Asia-Pacific GLP-1 Receptor Agonist Value ($) and Growth (%) by Type from 2019-2020
Table Asia-Pacific GLP-1 Receptor Agonist Value ($) and Growth (%) by Application from 2019-2020
Table Asia-Pacific GLP-1 Receptor Agonist Value ($) and Growth (%) by Countries from 2019-2020
Table Top Asia-Pacific GLP-1 Receptor Agonist Participants Value ($) and Market Share (%) in 2020
Figure Latin America GLP-1 Receptor Agonist Production and Growth Rate from 2014-2020
Figure Latin America GLP-1 Receptor Agonist Consumption and Growth Rate from 2014-2020
Table Latin America GLP-1 Receptor Agonist Import and Export from 2014-2020
Table Latin America GLP-1 Receptor Agonist Value ($) and Growth (%) by Type from 2019-2020
Table Latin America GLP-1 Receptor Agonist Value ($) and Growth (%) by Application from 2019-2020
Table Latin America GLP-1 Receptor Agonist Value ($) and Growth (%) by Countries from 2019-2020
Table Top Latin America GLP-1 Receptor Agonist Participants Value ($) and Market Share (%) in 2020
Figure Middle East & Africa GLP-1 Receptor Agonist Production and Growth Rate from 2014-2020
Figure Middle East & Africa GLP-1 Receptor Agonist Consumption and Growth Rate from 2014-2020
Table Middle East & Africa GLP-1 Receptor Agonist Import and Export from 2014-2020
Table Middle East & Africa GLP-1 Receptor Agonist Value ($) and Growth (%) by Type from 2019-2020
Table Middle East & Africa GLP-1 Receptor Agonist Value ($) and Growth (%) by Application from 2019-2020
Table Middle East & Africa GLP-1 Receptor Agonist Value ($) and Growth (%) by Countries from 2019-2020
Table Top Middle East & Africa GLP-1 Receptor Agonist Participants Value ($) and Market Share (%) in 2020
Table Company one Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Company one Sales and Growth Rate from 2014-2020
Figure Company one Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Company two Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Company two Sales and Growth Rate from 2014-2020
Figure Company two Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Company three Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Company three Sales and Growth Rate from 2014-2020
Figure Company three Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Company four Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Company four Sales and Growth Rate from 2014-2020
Figure Company four Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Company five Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Company five Sales and Growth Rate from 2014-2020
Figure Company five Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Company six Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Company six Sales and Growth Rate from 2014-2020
Figure Company six Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Company seven Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Company seven Sales and Growth Rate from 2014-2020
Figure Company seven Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Company eight Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Company eight Sales and Growth Rate from 2014-2020
Figure Company eight Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Company nine Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Company nine Sales and Growth Rate from 2014-2020
Figure Company nine Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Company ten Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Company ten Sales and Growth Rate from 2014-2020
Figure Company ten Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Company 11 Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Company 11 Sales and Growth Rate from 2014-2020
Figure Company 11 Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Company 12 Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Company 12 Sales and Growth Rate from 2014-2020
Figure Company 12 Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Company 13 Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Company 13 Sales and Growth Rate from 2014-2020
Figure Company 13 Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Company 14 Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Company 14 Sales and Growth Rate from 2014-2020
Figure Company 14 Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Company 15 Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Company 15 Sales and Growth Rate from 2014-2020
Figure Company 15 Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Global GLP-1 Receptor Agonist Value ($) and Growth Rate Forecast by Regions (2020-2026)
Table Global GLP-1 Receptor Agonist Production and Growth Rate Forecast by Regions (2020-2026)
Table Global GLP-1 Receptor Agonist Consumption and Growth Rate Forecast by Regions (2020-2026)
Table Global GLP-1 Receptor Agonist Production and Growth Rate Forecast by Types (2020-2026)
Table Global GLP-1 Receptor Agonist Consumption and Growth Rate Forecast by End-User/Applications (2020-2635)
Similar Reports
This new 68-country report from LeadingMarketResearch.com is available by region, country, market segment, section, or individual test.
The report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the global blood banking market during the next five years, and assist industry executives in developing effective business, new ...
- Publish Date: March 2, 2020
- $0
Hearing aids in the form of analog units have been traditionally present and used in India. Digital hearing units are finding increased growth in acceptability owing to the changing perceptions and growing base of the target consumer group. The Indian market is largely dependent on imports from foreign countries; domestic players in the country are ramping up their manufacturing facilities. The gr...
- Publish Date: March 10, 2011
- $950
The Indian medical devices market is largely dependent on imports from foreign countries. Although domestic players in the country are ramping up their manufacturing facilities, the foreign companies continue to enjoy a superior market share on account of their brand recognition, reliability, and technological superiority. The growing target base of consumers will boost sales and the market is exp...
- Publish Date: July 18, 2011
- $950
